Early onset Pomp disease is a rare disorder often diagnosed late. Hypotonia, muscle weakens and cardio respiratory dysfunction are its hallmark. Blood assay of the GAA enzyme is a sensitive and specific marker of the disease. Early intervention with enzyme replacement therapy (ERT) improves morbidity and long-term survival, however therapy is both costly and a lifelong requirement. Gene therapy which is on the horizon appears promising
Pompe disease (PD) is a metabolic myopathy caused by the deficiency of the lysosomal hydrolase acid ...
We report 4 cases of late onset glycogen storage disease type II (GSD II) or Pompe disease (OMIM #23...
Pompe disease (PD) is a glycogen storage disorder caused by deficient activity of acid alpha-glucosi...
Pompe disease (glycogen storage disease type II or acid maltase deficiency) is a lysosomal disorder ...
Pompe disease is a genetic disorder produced by mutations in the GAA gene leading to absence or redu...
Pompe disease is an autosomal recessive metabolic myopathy caused by the deficiency of the lysosomal...
Pompe disease is a rare metabolic disorder, due to mutations in the gene encoding acid alpha-glucosi...
Purpose of reviewThis review summarizes the clinical presentation and provides an update on the curr...
Pompe disease (acid alpha-glucosidase deficiency, OMIM 232300) is a rare lysosomal storage disorder ...
Pompe disease (PD) is an autosomal recessive disease caused by partial or complete deficiency of the...
Classic infantile Pompe disease (IPD) is a rare lysosomal storage disorder characterized by severe h...
Late-onset Pompe disease (LOPD) is an autosomal recessive disorder caused by deficiency of the enzym...
International audiencePompe disease (PD) is a monogenic disorder caused by mutations in the acid alp...
Juan Francisco Cabello,1 Deborah Marsden21Genetics and Metabolic Disease Laboratory, Nutrition and F...
The treatment of later-onset Pompe disease with enzyme replacement therapy may not lead to significa...
Pompe disease (PD) is a metabolic myopathy caused by the deficiency of the lysosomal hydrolase acid ...
We report 4 cases of late onset glycogen storage disease type II (GSD II) or Pompe disease (OMIM #23...
Pompe disease (PD) is a glycogen storage disorder caused by deficient activity of acid alpha-glucosi...
Pompe disease (glycogen storage disease type II or acid maltase deficiency) is a lysosomal disorder ...
Pompe disease is a genetic disorder produced by mutations in the GAA gene leading to absence or redu...
Pompe disease is an autosomal recessive metabolic myopathy caused by the deficiency of the lysosomal...
Pompe disease is a rare metabolic disorder, due to mutations in the gene encoding acid alpha-glucosi...
Purpose of reviewThis review summarizes the clinical presentation and provides an update on the curr...
Pompe disease (acid alpha-glucosidase deficiency, OMIM 232300) is a rare lysosomal storage disorder ...
Pompe disease (PD) is an autosomal recessive disease caused by partial or complete deficiency of the...
Classic infantile Pompe disease (IPD) is a rare lysosomal storage disorder characterized by severe h...
Late-onset Pompe disease (LOPD) is an autosomal recessive disorder caused by deficiency of the enzym...
International audiencePompe disease (PD) is a monogenic disorder caused by mutations in the acid alp...
Juan Francisco Cabello,1 Deborah Marsden21Genetics and Metabolic Disease Laboratory, Nutrition and F...
The treatment of later-onset Pompe disease with enzyme replacement therapy may not lead to significa...
Pompe disease (PD) is a metabolic myopathy caused by the deficiency of the lysosomal hydrolase acid ...
We report 4 cases of late onset glycogen storage disease type II (GSD II) or Pompe disease (OMIM #23...
Pompe disease (PD) is a glycogen storage disorder caused by deficient activity of acid alpha-glucosi...